The combination drug valsartan/sacubitril (LCZ696) reduced pulse wave velocity and aortic systolic blood pressure in patients with stable heart failure with reduced ejection fraction

Authors

Kobalava Z. , Villevalde S. , Tyukhmenev E. , Lukina O.O. , Babaeva L. , Zharikova E.

Journal

Publisher

Elsevier Science Publishing Company, Inc.

Language

English

Pages

335-335

State

Published

Volume

Year

2016

Cite

Article

Kotovskaya Y., Kobalava Z.H., Bogomaz A.A.

European Journal of Heart Failure. Vol. 18. 2016. P.. 269-269

Article

Soloveva A., Villevalde S., Kobalava Z.

European Journal of Heart Failure. Vol. 18. 2016. P.. 361-362